#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

smutek obezita muž bezradnost nadváha

Prevalence and Clinical Impact of Overweight and Obesity in the Hemophilia Population

30. 5. 2022 Source: Hemophilia with Movement

Obesity is classified as a lifestyle disease with increasing prevalence and a rising contribution to morbidity and mortality in the general population. The epidemic of overweight and obesity also does not spare individuals with hemophilia. According to epidemiological data, the prevalence of obesity is also increasing in this population, causing a number of complications in many health aspects.

IBD

Tofacitinib Helps Restore Intestinal Epithelial Barrier

The Janus kinase inhibitor (JAKi) tofacitinib was relatively recently approved for the treatment of…
30. 5. 2022 Source: Intestinal Inflammations
aktivní psoriatickou artritidou

Safety and Efficacy of Long-term Tofacitinib Therapy in Patients with Active Psoriatic Arthritis – Interim Results of the OPAL Balance Study

Tofacitinib is a potent selective inhibitor of the Janus kinase (JAK) family indicated for the…
30. 5. 2022 Source: Arthritis
cardiovascular disease arthritis

Cardiovascular Safety of Tofacitinib in Real-World Clinical Practice – Results of the STAR-RA Study

Recent results from the ORAL Surveillance clinical trial have raised concerns about the…
29. 5. 2022 Source: Arthritis
ULCEROZNI

Maintenance of Remission with Tofacitinib in Patients with UC – Results of the OCTAVE Open Study

Tofacitinib is indicated for the treatment of ulcerative colitis (UC) in cases where conventional…
28. 5. 2022 Source: Intestinal Inflammations
žena_dítě_příroda

Indication of Bilastine in Specific Patient Groups − Practical Tips for Clinical Practice

Bilastine is a non-sedating H1-antihistamine, which is very well tolerated by patients. It can be…
24. 5. 2022 Source: Allergic Reactions
žena_alergie_rýma_jaro

Bilastine in the treatment of allergic rhinitis – meta-analysis shows advantage of lower somnolence

A newly published systematic review and meta-analysis evaluate the efficacy and safety of bilastine…
24. 5. 2022 Source: Allergic Reactions
CHOPN_starý muž

Need for Early Intervention in COPD − A Suitable Time for Mucolytic Treatment

Chronic Obstructive Pulmonary Disease (COPD) ranks third among the leading causes of morbidity and…
24. 5. 2022 Source: Cough Therapy
Výzkum_grafy

What Did 3 Years of Data from the Czech National COPD Database Reveal?

In December of last year, the Czech multicenter research database on COPD was completed. This was…
24. 5. 2022 Source: Cough Therapy
preskribce léků

COPD is Treated Differently Across Europe – What Could Be the Reasons for This Variability?

As part of this year's Hradec Pneumological Days (HPD 2022), the head of the Pulmonary Clinic at…
24. 5. 2022 Source: Cough Therapy
1 64 65 66 67 68 157
Filter by speciality
Remove filters

Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#